Status:
UNKNOWN
Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre
Lead Sponsor:
University Hospital Tuebingen
Collaborating Sponsors:
Institute of Clinical Chemistry and Pathobiochemistry, Department of Internal Medicine
Conditions:
History of Covid-19, Seroprevalence
Eligibility:
All Genders
Brief Summary
A sequential combination of different antibodies test against SARS-CoV-2 is evaluated. The protocol included a rapid test and several ELISA tests within a defined cohort of healthcare workers.
Detailed Description
In the current pandemic, the assessment of actual COVID-19 infections plays an important role in the assessment of the risk and progress of the epidemic. Shortly, more and more rapid tests will be ava...
Eligibility Criteria
Inclusion
- Employees of the health facility described
- voluntary request for testing
Exclusion
- \- None
Key Trial Info
Start Date :
May 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04446338
Start Date
May 13 2020
End Date
August 1 2020
Last Update
June 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Tuebingen
Tübingen, Baden-Wurttemberg, Germany, 72076